Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore various ways to earn cash when pressed for time. Maximize your earning potential with efficient strategies tailored for busy schedules.
24,740 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
eBay rejected GameStop's unsolicited $56 billion takeover offer, labeling it neither credible attractive. The decisio...
Bitmine’s Ethereum hoard surges to 5.28 million ETH, placing the treasury near a 5% stake of total supply as the comp...
Broadcom faces a fast-changing AI compute cycle that could lift shares toward $630, backed by custom silicon demand a...
Ethereum trades near the $2,000 mark as institutional moves diverge: BitMine increases ETH holdings while BTC exposur...
When a judge dismisses trafficking battery claims, the immediate liability may fade, but the financial impact lingers...
CFO compensation rose about 8% in 2025 as long-term incentives surged last year—and long-term incentives now dominate...
A new analysis shows that retiring to Marco Island at 65 with a $1.5 million nest egg is possible, but only with a pa...
Only a small slice of workers over 50 tap catch-up contributions in 2026, even with higher limits. Inflation, housing...
SpaceX is exploring bold ways to run data centers in orbit, powered by solar energy. For NuScale Power investors, the...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...